BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16026229)

  • 1. Controversies in primary CNS lymphoma.
    Abrey LE
    Expert Rev Neurother; 2005 Jul; 5(4):459-64. PubMed ID: 16026229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary CNS lymphoma.
    Gerstner E; Batchelor T
    Expert Rev Anticancer Ther; 2007 May; 7(5):689-700. PubMed ID: 17492932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances for the treatment of primary central nervous system lymphoma (review).
    Yamanaka R; Tanaka R
    Oncol Rep; 2004 Sep; 12(3):563-8. PubMed ID: 15289838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary central nervous system lymphoma.
    Mohile NA; Abrey LE
    Semin Radiat Oncol; 2007 Jul; 17(3):223-9. PubMed ID: 17591569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary non-Hodgkin's lymphomas of the central nervous system. Still more questions than answers in the treatment?].
    Hansen PB; Jensen MK
    Ugeskr Laeger; 2007 Jun; 169(23):2187-9. PubMed ID: 17592682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Journal Club: Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.
    Alnahhas I; Malkin M
    Neurology; 2015 Dec; 85(24):e187-9. PubMed ID: 26668244
    [No Abstract]   [Full Text] [Related]  

  • 7. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment.
    Hormigo A; Abrey L; Heinemann MH; DeAngelis LM
    Br J Haematol; 2004 Jul; 126(2):202-8. PubMed ID: 15238140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebral hemorrhage as a late complication after CNS treatment of childhood lymphoma.
    Claviez A; Neubauer B; Link J; Schneppenheim R
    Klin Padiatr; 1998; 210(6):406-8. PubMed ID: 9871896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary central nervous system lymphoma--a single center experience].
    Mitrović Z; Radman I; Aurer I; Petranović D; Santek F; Labar B
    Lijec Vjesn; 2007 Dec; 129(12):391-5. PubMed ID: 18383741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
    Bierman P; Giglio P
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):597-609, v. PubMed ID: 16083825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Hodgkin's lymphoma and the CNS: prophylaxis and therapy in immunocompetent and HIV-positive individuals.
    Mazhar D; Stebbing J; Bower M
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):335-41. PubMed ID: 16503851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of non-Hodgkin's lymphoma of the central nervous system with BMPD chemotherapy followed by radiotherapy.
    Korfel A; Thiel E
    Leuk Lymphoma; 1998 Aug; 30(5-6):609-17. PubMed ID: 9711923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraocular non-Hodgkin's lymphoma and its therapy-- a case series of ten patients].
    Siepmann K; Rohrbach JM; Duncker G; Zierhut M
    Klin Monbl Augenheilkd; 2004 Apr; 221(4):266-72. PubMed ID: 15118956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma.
    Green MR; Chowdhary S; Lombardi KM; Chalmers LM; Chamberlain M
    Expert Rev Neurother; 2006 May; 6(5):635-52. PubMed ID: 16734512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab.
    Schulz H; Pels H; Schmidt-Wolf I; Zeelen U; Germing U; Engert A
    Haematologica; 2004 Jun; 89(6):753-4. PubMed ID: 15194546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
    Thomas X; Pavan L; Le QH
    Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.
    Gavrilovic IT; Hormigo A; Yahalom J; DeAngelis LM; Abrey LE
    J Clin Oncol; 2006 Oct; 24(28):4570-4. PubMed ID: 17008697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary central nervous system lymphomas: salvage treatment after failure to high-dose methotrexate.
    Reni M; Mazza E; Foppoli M; Ferreri AJ
    Cancer Lett; 2007 Dec; 258(2):165-70. PubMed ID: 17993246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary central nervous system lymphoma: curable without toxicity?
    DeAngelis LM
    Cancer J Sci Am; 1996; 2(3):137-9. PubMed ID: 9166513
    [No Abstract]   [Full Text] [Related]  

  • 20. Hematology. Individualized methotrexate dosing in primary CNS lymphoma.
    Abrey LE
    Nat Rev Clin Oncol; 2010 Jun; 7(6):306-7. PubMed ID: 20517339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.